Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

September 8, 2016

Conditions

Hereditary Orotic Aciduria

Interventions

DRUG

uridine triacetate

Trial Locations (2)

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

Children's Hospital of Michigan - Specialty Center Detroit, Detroit

All Listed Sponsors

lead

Wellstat Therapeutics

INDUSTRY

NCT02110147 - Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria | Biotech Hunter | Biotech Hunter